Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders

Schizophrenia Research
Birgitte FagerlundRalf P Hemmingsen

Abstract

Cognitive deficits have been found to be prevalent in early onset schizophrenia. Whether these deficits also characterise other early onset psychotic disorders to a similar degree is unclear, as very few comparative studies have been done. The primary purpose of this study was to compare the profile and severity of cognitive impairments in first-episode early onset psychotic patients who received the schizophrenia diagnosis to those diagnosed with other non-organic, non-affective psychotic disorders. The secondary purpose was to examine whether the profile of cognitive deficits, in terms of intelligence, executive functions, memory, attention and processing speed was global or specific. First-episode psychotic adolescents (N = 39) between the ages 11 and 17 years were included, 18 of whom were diagnosed with schizophrenia, and 21 with other non-organic, non-affective psychoses, using ICD-10 criteria. A healthy control group (N = 40) was included, matched on gender and age. Cognitive functions were assessed using WISC-III/R, the CANTAB battery, WCST, Trail Making B, fluency tasks, and Buschke's selective reminding task. A similar profile and level of impairment was found on measures of attention, executive functions, reaction ti...Continue Reading

Citations

Sep 22, 2009·European Archives of Psychiatry and Clinical Neuroscience·Arantzazu ZabalaIgor Bombín
Sep 6, 2008·Journal of Clinical and Experimental Neuropsychology·Marie-Claire DoréNancie Rouleau
Sep 19, 2009·European Child & Adolescent Psychiatry·Jens Richardt Moellegaard JepsenErik L Mortensen
Aug 4, 2010·European Child & Adolescent Psychiatry·Jens Richardt M JepsenErik L Mortensen
May 21, 2010·Psychological Medicine·L T FikkeN I Landrø
Dec 12, 2012·Journal of Autism and Developmental Disorders·Antonio NarzisiCosimo Urgesi
Sep 10, 2013·Child and Adolescent Psychiatric Clinics of North America·Sophia Frangou
Jul 9, 2013·Revista de psiquiatrí́a y salud mental·Josefa María Moreno-GranadosMiguel Ruiz-Veguilla
Dec 1, 2008·Revista de psiquiatrí́a y salud mental·Arantzazu ZabalaMiguel Gutiérrez
Feb 23, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Daniel P DicksteinEllen Leibenluft
Jun 22, 2013·Scandinavian Journal of Psychology·Jens Richardt Møllegaard JepsenErik Lykke Mortensen
Oct 26, 2011·Journal of Child Psychology and Psychiatry, and Allied Disciplines·M MayoralC Arango
Jan 29, 2011·Early Intervention in Psychiatry·Nora S VyasBasant K Puri
Apr 3, 2009·Journal of Neuropsychology·Julie BoutinNancie Rouleau
Mar 20, 2010·Acta Anaesthesiologica Scandinavica·J TorgersenH Flaatten
Nov 28, 2012·Schizophrenia Research·Elena de la SernaJosefina Castro-Fornieles
Sep 19, 2012·Psychiatry Research·Itxaso González-OrtegaAna González-Pinto
Mar 29, 2011·The Australian and New Zealand Journal of Psychiatry·Cali F BartholomeuszStephen J Wood
Sep 26, 2008·Journal of Attention Disorders·Jens Richardt M JepsenErik Lykke Mortensen
Jun 29, 2018·Journal of Evidence-informed Social Work·Annahita BallEugene Maguin
Jan 1, 2014·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N V Zvereva, A I Khromov
Jan 7, 2022·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Nora S VyasMonte S Buchsbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here